The binding of antigenic peptides to HLA-DR is influenced by interactions between pocket 6 and pocket 9

Journal of Immunology

Volumn 183, Issue 5, 2009, Pages 3249-3258

  James, Eddie A ^a   Moustakas, Antonis K ^c   Bui, John ^a   Nouv, Randi ^a   Papadopoulos, George K ^d   Kwok, William W ^a,b  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c IONIAN UNIVERSITY   (Greece)

^d Faculty of Agricultural Technology   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; HLA DR ANTIGEN; LYSINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POCKET 6 PROTEIN; POCKET 9 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; HLA DR3 ANTIGEN; HLA DR9; HLA-DR9; HLA-DRA; HLA-DRB1 ANTIGEN; PEPTIDE;

ANTIGEN BINDING; ARTICLE; HUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; AMINO ACID SUBSTITUTION; BINDING COMPETITION; CHEMISTRY; COMPARATIVE STUDY; IMMUNOLOGY; METABOLISM; PROTEIN MOTIF; T LYMPHOCYTE;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; BINDING, COMPETITIVE; EPITOPES, T-LYMPHOCYTE; HLA-DR ANTIGENS; HLA-DR3 ANTIGEN; HUMANS; PEPTIDES; PROTEIN BINDING; T-LYMPHOCYTES;

EID: 70349240535     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802228     Document Type: Article

References (29)

1. Bondinas, G. P., A. K. Moustakas, and G. K. Papadopoulos. 2007. The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function. Immunogenetics 59: 539-553.
2. Murthy, V. L., and L. J. Stern. 1997. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure 5: 1385-1396.
3. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378: 457-462.
4. Stern, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215-221.
5. Sturniolo, T., E. Bono, J. Ding, L. Raddrizzani, O. Tuereci, U. Sahin, M. Braxenthaler, F. Gallazzi, M. P. Protti, F. Sinigaglia, and J. Hammer. 1999. Generation of tissue-specific and promiscuous HLA ligand database using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol. 17: 555-561.
6. Anderson, M. W., and J. Gorski. 2005. Cooperativity during the formation of peptide/MHC class II complexes. Biochemistry 44: 5617-5624.
7. Ferrante, A., and J. Gorski. 2007. Cooperativity of hydrophobic anchor interactions: evidence for epitope selection by MHC class II as a folding process. J. Immunol. 178: 7181-7189.
8. Itoh, A., A. Shimada, K. Kodama, J. Morimoto, R. Suzuki, Y. Oikawa, J. Irie, Y. Nakagawa, T. Shigihara, Y. Kanazawa, et al. 2004. GAD-reactive T cells were mainly detected in autoimmune-related type 1 diabetic patients with HLA DR9. Ann. NY Acad. Sci. 1037: 33-40.
9. Imagawa, A., T. Hanafusa, Y. Uchigata, A. Kanatsuka, E. Kawasaki, T. Kobayashi, A. Shimada, I. Shimizu, T. Maruyama, and H. Makino. 2005. Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia 48: 294-300.
10. Murao, S., H. Makino, Y. Kaino, E. Konoue, J. Ohashi, K. Kida, Y. Fujii, I. Shimizu, E. Kawasaki, M. Fujiyama, et al. 2004. Differences in the contribution of HLA-DR and -DQ haplotypes to susceptibility to adult- and childhood-onset type 1 diabetes in Japanese patients. Diabetes 53: 2684-2690.
11. Park, Y. S., C. Y. Wang, K. W. Ko, S. W. Yang, M. Park, M. C. Yang, and J. X. She. 1998. Combinations of HLA DR and DQ molecules determine the susceptibility to insulin-dependent diabetes mellitus in Koreans. Hum. Immunol. 59: 794-801.
12. Sugihara, S., T. Sakamaki, S. Konda, A. Murata, K. Wataki, Y. Kobayashi, K. Minamitani, S. Miyamoto, N. Sasaki, and H. Niimi. 1997. Association of HLA-DR, DQ genotype with different β-cell functions at IDDM diagnosis in Japanese children. Diabetes 46: 1893-1897.
13. Kumagai, T., T. Yamanaka, Y. Wataya, A. Saito, T. Okui, S. Yano, H. Tsutsumi, S. Chiba, and A. Wakisaka. 2001. A strong association between HLA-DR9 and gelatin allergy in the Japanese population. Vaccine 19: 3273-3276.
14. Fujisao, S., S. Matsushita, T. Nishi, and Y. Nishimura. 1996. Identification of HLA-DR9 (DRB1*0901)-binding peptide motifs using a phage fUSE5 random peptide library. Hum. Immunol. 45: 131-136.
15. Fujisao, S., Y. Nishimura, and S. Matsushita. 1997. Evaluation of peptide-HLA binding by an enzyme-linked assay and its application to the detailed peptide motifs for HLA-DR9 (DRB1*0901). J. Immunol. Methods 201: 157-163.
16. + T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104: R63-R67.
17. + T cell epitopes from complex antigens. J. Immunol. 166: 6665-6670.
18. Ettinger, R. A., and W. W. Kwok. 1998. A peptide binding motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus. J. Immunol. 160: 2365-2373.
19. Reichstetter, S., G. K. Papadopoulos, A. K. Moustakas, E. Swanson, A. W. Liu, S. Beheray, R. A. Ettinger, G. T. Nepom, and W. W. Kwok. 2002. Mutational analysis of critical residues determining antigen presentation and activation of HLA-DQ0602-restricted T cell clones. Hum. Immunol. 63: 185-193.
20. Ettinger, R. A., G. K. Papadopoulos, A. K. Moustakas, G. T. Nepom, and W. W. Kwok. 2006. Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. J. Immunol. 176: 1988-1998.
21. + T cells and suggests HLA-based differences in epitope recognition. Int. Immunol. 19: 1291-1301.
22. Geluk, A., K. E. van Meijgaarden, S. Southwood, C. Oseroff, J. W. Drijfhout, R. R. de Vries, T. H. Ottenhoff, and A. Sette. 1994. HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs. J. Immunol. 152: 5742-5748.
23. Vartdal, F., B. H. Johansen, T. Friede, C. J. Thorpe, S. Stevanović, J. E. Eriksen, K. Sletten, E. Thorsby, H.-G. Rammensee, and L. M. Sollid. 1996. The peptide binding motif of the disease associated HLA-DQ (α1*0501/β1*0201) molecule. Eur. J. Immunol. 26: 2764-2772.
24. Van de Wal, Y., Y. M. Kooy, J. W. Drijfhout, R. Amons, G. K. Papadopoulos, and F. Koning. 1997. Unique peptide binding characteristics of the disease-associated DQ(α1*0501, β1*0201) vs the non-disease-associated DQ(α1*0201,β1*0202) molecule. Immunogenetics 46: 484-492.
25. Koelle, D. M., M. L. Johnson, A. N. Ekstrom, P. Byers, and W. W. Kwok. 1997. Preferential presentation of herpes simplex virus T cell antigen by HLA DQA1*0501/DQB1*0201 in comparison to HLA DQA1*0201/ DQB1*0201. Hum. Immunol. 53: 195-205.
26. Stepniak, D., M. Wiesner, A. H. de Ru, A. K. Moustakas, G. K. Papadopoulos, P. A. van Veelen, and F. Koning. 2008. Large scale characterization of natural ligands explains the unique binding properties of HLA-DQ2. J. Immunol. 180: 3268-3278.
27. Kim, C.-Y., H. Quarsten, E. Bergseng, C. Khosla, and L. M. Sollid. 2004. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl. Acad. Sci. USA 101: 4175-4179.
28. James, E. A., A. K. Moustakas, D. Berger, L. Huston, G. K. Papadopoulos, and W. W. Kwok. 2008. Definition of the peptide binding motif within novel DRB1*1401 restricted epitopes by peptide competition and structural modeling. Mol. Immunol. 45: 2651-2659.
29. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272: 1001-1004. (Pubitemid 26259315)